Company intelligence / Profile preview

Iconeus

Ownership: Private
Development stage: Commercial

Overview

Iconeus has commercialized the first easy-to-use functional ultrasound system ("Iconeus One") for high-resolution imaging of brain function and vasculature. The technology enables sensitive, fast mapping of cerebral blood flow in preclinical animal models and has begun to be adopted for human clinical research. It supports studies ranging from basic neuroscience to investigations of neurological diseases such as stroke or neurodegeneration. No direct clinical results as it’s an enabling tool rather than a therapeutic.

Therapeutic areas: OtherNeurology
Modalities: Device (Functional ultrasound imaging system)
Industry: Medical Imaging

Partnerships

Collaborations with academic institutions such as ESPCI Parisfield-testing with over ten early adopter labs worldwide.

Beyond the preview

Go deeper on Iconeus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iconeus.

Explore the full profile